Pharmakologie der ADP-Rezeptoren auf humanen Thrombozyten

93. Mehta, S.R. and S. Yusuf. 2000. The Clopidogrel in Unstable angina to prevent Recurrent Events
(CURE) trial programme; rationale, design and baseline characteristics including a metaanalysis
of the effects of thienopyridines in vascular disease. Eur Heart J 21:2033-2041.
94. Michelson, A.D., S.E. Benoit, M.I. Furman, W.L. Breckwoldt, M.J. Rohrer, M.R. Barnard, and J.
Loscalzo. 1996. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol
270:H1640-H1648
95. Mills, D.C. 1996. ADP receptors on platelets. Thromb Haemost 76:835-856.
96. Mueller, T., M. Haltmayer, W. Poelz, and D. Haidinger. 2003. Monitoring Aspirin 100 mg and
Clopidogrel 75 mg Therapy with the PFA-100 Device in Patients with Peripheral Arterial
Disease. Vasc Endovascular Surg 37:117-123.
97. Mulryan, K., D.P. Gitterman, C.J. Lewis, C. Vial, B.J. Leckie, A.L. Cobb, J.E. Brown, E.C. Conley, G.
Buell, C.A. Pritchard, and R.J. Evans. 2000. Reduced vas deferens contraction and male
infertility in mice lacking P2X1 receptors. Nature 403:86-89.
98. Nachmias, V.T., J. Kavaler, and S. Jacubowitz. 1985. Reversible association of myosin with the
platelet cytoskeleton. Nature 313:70-72.
99. Nieswandt, B., C. Brakebusch, W. Bergmeier, V. Schulte, D. Bouvard, N. Mokhtari, T. Lindhout, J.W.
Heemskerk, H. Zirngibl, and R. Fassler. 2001. Glycoprotein VI but not alpha2beta1 integrin is
essential for platelet interaction with collagen. EMBO J 20:2120-2130.
100. Nolte, C., M. Eigenthaler, P. Schanzenbacher, and U. Walter. 1991. Endothelial cell-dependent
phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors. J Biol
Chem 266:14808-14812.
101. North, R.A. and E.A. Barnard. 1997. Nucleotide receptors. Curr Opin Neurobiol 7:346-357.
102. Offermanns, S. 2000. The role of heterotrimeric G proteins in platelet activation. Biol Chem 381:389-
396.
103. Offermanns, S., C.F. Toombs, Y.H. Hu, and M.I. Simon. 1997. Defective platelet activation in G
alpha(q)-deficient mice. Nature 389:183-186.
104. Ohlmann, P., A. Eckly, M. Freund, J.P. Cazenave, S. Offermanns, and C. Gachet. 2000. ADP
induces partial platelet aggregation without shape change and potentiates collagen-induced
aggregation in the absence of Galphaq. Blood 96:2134-2139.
105. Ostrom, R.S. 2002. New determinants of receptor-effector coupling: trafficking and compartmentation
in membrane microdomains. Mol Pharmacol 61:473-476.
106. Oury, C., M.J. Kuijpers, Z. Toth, A. Bonnefoy, S. Danloy, I. Vreys, M.A. Feijge, V. De, J. Vermylen,
J.W. Heemskerk, and M.F. Hoylaerts. 2003. Overexpression of the platelet P2X1 ion channel
in transgenic mice generates a novel prothrombotic phenotype. Blood 101:3969-3976.
107. Oury, C., Z. Toth, G. Van, C. Thys, L. Wei, B. Nilius, J. Vermylen, and M.F. Hoylaerts. 2000. A natural
dominant negative P2X1 receptor due to deletion of a single amino acid residue. J Biol
Chem 275:22611-22614.
108. Palmer, R.K., J.L. Boyer, J.B. Schachter, R.A. Nicholas, and T.K. Harden. 1998. Agonist action of
adenosine triphosphates at the human P2Y1 receptor. Mol Pharmacol 54:1118-1123.
109. Parker, K.E. 1998. Modulation of ATP-gated non-selective cation channel (P2X1 receptor) activation
and desensitization by the actin cytoskeleton. J Physiol 510 ( Pt 1):19-25.
110